EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -1.994
March 31, 2026 -2.755
December 31, 2025 -3.210
September 30, 2025 -3.462
June 30, 2025 -3.317
March 31, 2025 -3.178
December 31, 2024 -3.221
September 30, 2024 -3.143
June 30, 2024 -3.271
March 31, 2024 -3.393
December 31, 2023 -3.724
September 30, 2023 -4.227
June 30, 2023 -4.683
March 31, 2023 -4.830
December 31, 2022 -4.787
September 30, 2022 -4.832
June 30, 2022 -5.048
March 31, 2022 -5.047
December 31, 2021 -4.958
Date Value
September 30, 2021 -5.067
June 30, 2021 -5.024
March 31, 2021 -5.290
December 31, 2020 -5.911
September 30, 2020 -6.390
June 30, 2020 -6.148
March 31, 2020 -5.786
December 31, 2019 -5.108
September 30, 2019 -4.714
June 30, 2019 -4.926
March 31, 2019 -4.990
December 31, 2018 -4.757
September 30, 2018 -4.034
June 30, 2018 -2.778
March 31, 2018 -2.336
December 31, 2017 -1.46
September 30, 2017 -0.72
June 30, 2017 -0.70

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Xencor, Inc. -2.170
MeiraGTx Holdings Plc 0.7057
Insmed, Inc. -4.105
Ironwood Pharmaceuticals, Inc. 0.7668
Viking Therapeutics, Inc. -4.662